PT2922551T - Novos compostos como inibidores de diacilglicerol aciltransferase - Google Patents

Novos compostos como inibidores de diacilglicerol aciltransferase

Info

Publication number
PT2922551T
PT2922551T PT13856479T PT13856479T PT2922551T PT 2922551 T PT2922551 T PT 2922551T PT 13856479 T PT13856479 T PT 13856479T PT 13856479 T PT13856479 T PT 13856479T PT 2922551 T PT2922551 T PT 2922551T
Authority
PT
Portugal
Prior art keywords
new compounds
diacylglycerol acyltransferase
acyltransferase inhibitors
inhibitors
diacylglycerol
Prior art date
Application number
PT13856479T
Other languages
English (en)
Portuguese (pt)
Inventor
Cheung Mui
S Tangirala Raghuram
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of PT2922551T publication Critical patent/PT2922551T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epidemiology (AREA)
PT13856479T 2012-11-23 2013-11-22 Novos compostos como inibidores de diacilglicerol aciltransferase PT2922551T (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3593DE2012 2012-11-23
IN750DE2013 2013-03-14
IN3172DE2013 2013-10-25

Publications (1)

Publication Number Publication Date
PT2922551T true PT2922551T (pt) 2019-02-04

Family

ID=50776577

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13856479T PT2922551T (pt) 2012-11-23 2013-11-22 Novos compostos como inibidores de diacilglicerol aciltransferase

Country Status (31)

Country Link
US (1) US20150322082A1 (enExample)
EP (2) EP2922551B1 (enExample)
JP (1) JP6279600B2 (enExample)
KR (1) KR102176463B1 (enExample)
CN (1) CN104918620B (enExample)
AU (1) AU2013347843B2 (enExample)
BR (1) BR112015011982A8 (enExample)
CA (1) CA2892304C (enExample)
CL (1) CL2015001397A1 (enExample)
CY (1) CY1121426T1 (enExample)
DK (1) DK2922551T3 (enExample)
EA (1) EA031114B1 (enExample)
ES (1) ES2708626T3 (enExample)
HR (1) HRP20190099T1 (enExample)
HU (1) HUE042483T2 (enExample)
IL (1) IL238835B (enExample)
LT (1) LT2922551T (enExample)
ME (1) ME03315B (enExample)
MX (1) MX363484B (enExample)
NZ (1) NZ630436A (enExample)
PE (1) PE20150967A1 (enExample)
PH (1) PH12015501109A1 (enExample)
PL (1) PL2922551T3 (enExample)
PT (1) PT2922551T (enExample)
RS (1) RS58539B1 (enExample)
SG (1) SG11201503761WA (enExample)
SI (1) SI2922551T1 (enExample)
SM (1) SMT201900230T1 (enExample)
UA (1) UA115079C2 (enExample)
WO (1) WO2014081994A1 (enExample)
ZA (1) ZA201503304B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018052818A (ja) * 2015-01-28 2018-04-05 武田薬品工業株式会社 スルホンアミド化合物
KR20190085035A (ko) * 2016-11-18 2019-07-17 머크 샤프 앤드 돔 코포레이션 디아실글리세리드 o-아실트랜스퍼라제 2의 억제제로서 유용한 인돌 유도체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100795462B1 (ko) * 2006-09-27 2008-01-16 한국생명공학연구원 인돌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 대사성 질환 예방 및 치료용 약학적 조성물
US20090036425A1 (en) * 2007-08-02 2009-02-05 Pfizer Inc Substituted bicyclolactam compounds
US20090076275A1 (en) * 2007-09-19 2009-03-19 David Robert Bolin Diacylglycerol acyltransferase inhibitors
AR066169A1 (es) * 2007-09-28 2009-07-29 Novartis Ag Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat
US8324385B2 (en) * 2008-10-30 2012-12-04 Madrigal Pharmaceuticals, Inc. Diacylglycerol acyltransferase inhibitors
WO2010086820A1 (en) * 2009-02-02 2010-08-05 Pfizer Inc. 4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof
WO2011121350A1 (en) * 2010-04-01 2011-10-06 Astrazeneca Ab 4 -amino -7,8- dihydropyrimido [5, 4 - f] [1, 4] oxazepin- 5 ( 6h) - one based dgat1 inhibitors
DK2710013T3 (en) 2011-05-20 2016-09-26 Glaxosmithkline Intellectual Property (No 2) Ltd New compounds such as diacylglycerol-acyltransferase inhibitors

Also Published As

Publication number Publication date
MX363484B (es) 2019-03-21
CA2892304C (en) 2021-03-30
WO2014081994A1 (en) 2014-05-30
DK2922551T3 (en) 2019-02-18
CN104918620A (zh) 2015-09-16
IL238835A0 (en) 2015-06-30
SI2922551T1 (sl) 2019-05-31
CL2015001397A1 (es) 2015-08-28
JP2016500109A (ja) 2016-01-07
ME03315B (me) 2019-10-20
EP2922551A1 (en) 2015-09-30
AU2013347843B2 (en) 2016-06-16
HUE042483T2 (hu) 2019-06-28
PE20150967A1 (es) 2015-06-25
UA115079C2 (uk) 2017-09-11
KR102176463B1 (ko) 2020-11-09
EA031114B1 (ru) 2018-11-30
US20150322082A1 (en) 2015-11-12
EA201590982A1 (ru) 2015-11-30
SMT201900230T1 (it) 2019-07-11
HK1214757A1 (en) 2016-08-05
RS58539B1 (sr) 2019-04-30
SG11201503761WA (en) 2015-06-29
PL2922551T3 (pl) 2019-06-28
CA2892304A1 (en) 2014-05-30
PH12015501109B1 (en) 2015-08-17
BR112015011982A8 (pt) 2019-10-08
LT2922551T (lt) 2019-02-11
AU2013347843A1 (en) 2015-05-28
CN104918620B (zh) 2017-06-09
HRP20190099T1 (hr) 2019-04-19
JP6279600B2 (ja) 2018-02-14
NZ630436A (en) 2016-08-26
EP3492474B1 (en) 2021-08-11
ES2708626T3 (es) 2019-04-10
MX2015006533A (es) 2015-08-06
PH12015501109A1 (en) 2015-08-17
IL238835B (en) 2019-07-31
EP2922551B1 (en) 2018-10-31
EP3492474A1 (en) 2019-06-05
CY1121426T1 (el) 2020-05-29
EP2922551A4 (en) 2016-04-27
KR20150087852A (ko) 2015-07-30
ZA201503304B (en) 2016-05-25
BR112015011982A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
CO6811855A2 (es) Compuestos novedosos como inhibidores de diacilglicerol aciltransferasa
PT3459942T (pt) Inibidores de adn-pk
CO7010838A2 (es) Compuestos de imidazopirrolidinona
CO7061086A2 (es) Combinaciones de compuestos activos
CO6880068A2 (es) Aminoquinazolinas como inhibidores de quinasa
CO6920291A2 (es) 3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idhmutante
PT3068786T (pt) Compostos de pirazolopirimidina
BR112013015449A2 (pt) compostos de bi-heteroarila como inibidores de vps23
IL234928A0 (en) Inhibitors of diacylglycerol acyltransferase 2 and their uses
BR112014023606A2 (pt) Bandeja de testemunho
CO6862145A2 (es) Imidazopiridazinas como inhibidores de quinasa akt
DK2804611T3 (da) Chitosanafledte forbindelser
EP2911563A4 (en) DONOR
EP2858975A4 (en) FBXO3 INHIBITORS
CO6811853A2 (es) Compuestos novedosos como inhibidores de diacilglicerol aciltransferasa
BR112013005210A2 (pt) compostos heterocíclicos como inibidores de dgat1
PT2922551T (pt) Novos compostos como inibidores de diacilglicerol aciltransferase
BR112013029805A2 (pt) novos compostos como inibidores de diacilglicerol aciltransferase
FR2997080B1 (fr) Inhibiteurs de neprilysine
ES2390324B8 (es) Juego de brocas
TH1301007216B (th) สารประกอบโครมีน